Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer

ET Bauernhofer; Tina Moser; Anna Eberhard; Nina Monsberger; Matthias Moser; Lisa Glawitsch; Sabrina Hammer; Georgios Vlachos; Leandra Ziegler; Jochen Bernd Geigl; Thomas Bauernhofer; Ellen Heitzer

doi:10.1016/j.annonc.2025.08.3135

Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer

ET Bauernhofer
, Tina Moser
, Anna Eberhard
, Nina Monsberger
, Matthias Moser
, Lisa Glawitsch
, Sabrina Hammer
, Georgios Vlachos
, Leandra Ziegler
, Jochen Bernd Geigl
, Thomas Bauernhofer
, Ellen Heitzer

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Annals of Oncology
DOIs	https://doi.org/10.1016/j.annonc.2025.08.3135
Publication status	Published - 2025
Event	ESMO Congress 2025 - Berlin, Germany Duration: 17 Oct 2025 → 21 Oct 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

102 Computer Sciences
106 Biology
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine
305 Other Human Medicine, Health Sciences

DOI

10.1016/j.annonc.2025.08.3135

Links

Web of Science

Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
Bauernhofer, E. (Author), Moser, T. (Author), Eberhard, A. (Author), Monsberger, N. (Author), Moser, M. (Author), Glawitsch, L. (Author), Hammer, S. (Author), Vlachos, G. (Author), Ziegler, L. (Author), Geigl, J. B. (Author), Bauernhofer, T. (Author) & Heitzer, E. (Author)
2025
Activity: Talk, presentation or poster › Poster

Cite this

@article{3edea08a7dde4d0197662b14ac161733,

title = "Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer",

author = "ET Bauernhofer and Tina Moser and Anna Eberhard and Nina Monsberger and Matthias Moser and Lisa Glawitsch and Sabrina Hammer and Georgios Vlachos and Leandra Ziegler and Geigl, \{Jochen Bernd\} and Thomas Bauernhofer and Ellen Heitzer",

year = "2025",

doi = "10.1016/j.annonc.2025.08.3135",

language = "English",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

note = "ESMO Congress 2025 ; Conference date: 17-10-2025 Through 21-10-2025",

}

TY - JOUR

T1 - Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer

AU - Bauernhofer, ET

AU - Moser, Tina

AU - Eberhard, Anna

AU - Monsberger, Nina

AU - Moser, Matthias

AU - Glawitsch, Lisa

AU - Hammer, Sabrina

AU - Vlachos, Georgios

AU - Ziegler, Leandra

AU - Geigl, Jochen Bernd

AU - Bauernhofer, Thomas

AU - Heitzer, Ellen

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:1632203000095

U2 - 10.1016/j.annonc.2025.08.3135

DO - 10.1016/j.annonc.2025.08.3135

M3 - Conference abstract

SN - 0923-7534

JO - Annals of Oncology

JF - Annals of Oncology

T2 - ESMO Congress 2025

Y2 - 17 October 2025 through 21 October 2025

ER -

Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer

UN SDGs

Branches of science

DOI

Links

Activities

Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer

Cite this